Space Economy Set for Strong Growth Cycle
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2026
0mins
Should l Buy RKLB?
Source: Fool
- Optimistic Market Outlook: According to McKinsey, the global space economy is projected to reach $1.8 trillion by 2035, indicating strong growth potential that attracts investor interest.
- Rocket Lab's Competitiveness: Rocket Lab has achieved 81 launches in the U.S., making it the second-largest launch company after SpaceX, and its upcoming Neutron rocket aims to carry payloads 40 times larger than its current Electron rocket, enhancing profit margins and market competitiveness.
- AST SpaceMobile's Strategic Partnerships: AST SpaceMobile has secured significant agreements with telecom giants like AT&T and Verizon to provide broadband coverage through its satellite network, with revenue expected to grow from $57 million in 2025 to $1.94 billion by 2028, showcasing its market potential.
- Divergent Profitability Expectations: While both companies are currently unprofitable, analysts project Rocket Lab will achieve profitability by 2027, whereas AST SpaceMobile is expected to reach it by 2028, reflecting differing market perceptions of their future developments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RKLB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RKLB
Wall Street analysts forecast RKLB stock price to rise
11 Analyst Rating
7 Buy
4 Hold
0 Sell
Moderate Buy
Current: 78.590
Low
63.00
Averages
86.89
High
120.00
Current: 78.590
Low
63.00
Averages
86.89
High
120.00
About RKLB
Rocket Lab Corporation is an end-to-end space company. The Company designs and manufactures small and medium-class rockets, spacecraft and spacecraft components, and related software and services to support the space economy. The Company delivers reliable launch services, satellite manufacture, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions that make it easier to access space. Its Launch Services segment provides launch and launch-related services to customers on a dedicated mission or ride-share basis. Its Space Systems segment comprises the design and manufacture of spacecraft components and spacecraft program management services, space data applications, and mission operations. Its space systems solutions are the building blocks for spacecraft, which include composite structures, reaction wheels, star trackers, solar solutions, radios, separation systems, and command and control spacecraft software.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analyzing Rocket Lab's Market Prospects
- Market Opportunity: With increasing investments in satellite constellations by governments and companies, Rocket Lab (NASDAQ: RKLB) is positioned in a rapidly growing market, with projections estimating the market size to reach $1 trillion by 2025, indicating significant potential benefits for the company.
- Revenue Growth: In Q4 2023, Rocket Lab reported a 36% year-over-year revenue increase to $180 million, primarily driven by new launch contracts with government and commercial clients, showcasing its competitive edge in the aerospace sector.
- Profitability Challenges: Despite revenue progress, the company faces an operating loss of $51 million, largely due to rising R&D costs, highlighting significant hurdles that must be overcome before achieving profitability.
- Valuation Risks: With a market cap of $49 billion and a price-to-sales ratio of 79, significantly higher than the S&P 500's 3.5, Rocket Lab's stock price is under considerable downward pressure, necessitating careful evaluation of its future growth potential.
See More
U.S. Space Force Budget Reaches $71 Billion
- Significant Budget Increase: The U.S. Space Force's budget has reached $71 billion, with $40 billion allocated for research and development of new space infrastructure, indicating a strong demand for advanced technologies that could boost stock prices of related companies.
- Surge in Material Demand: In 2026, demand for aerospace and defense thermoplastic composites surged by 32% year-over-year to $731 million, highlighting a supply chain gap that may funnel capital toward companies positioned to address this mismatch.
- Expanded Technical Collaboration: Starfighters Space has broadened its technical interchange agreement with Blackstar Orbital to include vehicle integration and wind tunnel testing, enhancing their collaborative potential in hypersonic spacecraft development, which could accelerate time-to-market for new products.
- Optimistic Market Outlook: Karman reported a fiscal year 2025 revenue of $471.5 million, up 36.6%, and raised its 2026 revenue outlook to $715 million to $730 million, reflecting strong growth trends in the defense and space markets that may attract more investor interest.
See More
U.S. Space Force Budget Reaches $71 Billion
- Significant Budget Increase: The U.S. Space Force's budget has reached $71 billion, with $40 billion allocated for research and development of new space infrastructure, indicating a pressing need for advanced technologies in the defense industrial base as funding flows in faster than facilities and workforce can absorb.
- Surge in Material Demand: In 2026, demand for aerospace and defense thermoplastic composites surged 32% year-over-year to $731 million, highlighting a structural mismatch between defense industrial needs and supply chain capabilities, which is directing capital towards companies positioned at the bottleneck.
- Expanded Technical Collaboration: Starfighters Space has broadened its technical interchange with Blackstar Orbital to include integration engineering and wind tunnel testing, aiming to accelerate the flight testing of reusable hypersonic spacecraft, thereby enhancing their partnership in the aerospace sector.
- Optimistic Market Outlook: Karman reported a fiscal year 2025 revenue of $471.5 million, up 36.6%, and raised its 2026 revenue outlook to $715 million to $730 million, reflecting strong demand in national security and commercial space access markets.
See More
Rocket Lab Expands Business Through Defense Contracts and Acquisitions
- Defense Contract Growth: Rocket Lab is significantly expanding its business through defense contracts, indicating a growing market potential in the defense sector that could provide strong support for future revenue growth.
- Acquisition Strategy: The company enhances its satellite systems capabilities through acquisitions, which not only boosts its technological strength but also positions it to capture more market share in the competitive aerospace industry, further solidifying its market position.
- New Rocket Development: Rocket Lab is developing the Neutron rocket, which is expected to bring new revenue streams, particularly in the commercial launch services sector, thereby enhancing its competitive edge in the market.
- Valuation and Execution Risks: Despite the optimistic outlook, the stock's premium valuation means that execution is critical, and investors need to monitor the company's ability to sustain growth to avoid potential price correction risks.
See More
ARK Investment Management Increases NTLA Holdings
- Consistent NTLA Accumulation: ARK Investment Management has steadily increased its holdings in Intellia Therapeutics (NTLA) throughout 2026, acquiring over 263,848 shares from January to April, with a potential investment exceeding $3.5 million, reflecting a strong long-term confidence in the biotech firm.
- Positive Clinical Trial Results: Intellia recently reported positive Phase 3 trial results for lonvoculin ziclumeran (lonvo-z) for hereditary angioedema treatment and has initiated a rolling Biologics License Application submission to the FDA, aiming for a potential U.S. launch in the first half of 2027.
- Rocket Lab Stock Sale: ARK's second sale of Rocket Lab (RKLB) stock this month involved offloading 50,312 shares, potentially worth over $4 million, indicating a strategy to lock in gains after RKLB's impressive 262% rise over the past year.
- Retail Investor Sentiment: On Stocktwits, retail sentiment for NTLA is in the 'extremely bullish' territory, while RKLB is 'bullish', suggesting positive market expectations for both stocks, despite ARKK and ARKQ showing 'bearish' sentiment.
See More
Jim Cramer's Insights on Various Stocks
- Joby Aviation Risk Assessment: Joby Aviation is deemed too risky, with analysts advising new investors to be cautious to avoid disappointment from potential stock price drops, which could hinder its ability to attract new investors.
- BillionToOne Potential: Despite the overall poor performance of diagnostic companies, BillionToOne is viewed as a potential winner, with analysts believing its future performance is promising, which may draw more investor interest in its stock.
- Boston Scientific Competitive Pressure: Boston Scientific faces intense competition, with analysts noting that its market position is under threat; however, there is still potential for a rebound, prompting investors to watch for a price bottom before deciding to buy.
- Rocket Lab Investment Opportunity: Rocket Lab is considered a speculative stock worth investing in, with analysts optimistic about its future performance, especially leading up to the SpaceX IPO, which could attract more speculative investments.
See More
Analyzing Rocket Lab's Market Prospects
- Market Opportunity: With increasing investments in satellite constellations by governments and companies, Rocket Lab (NASDAQ: RKLB) is positioned in a rapidly growing market, with projections estimating the market size to reach $1 trillion by 2025, indicating significant potential benefits for the company.
- Revenue Growth: In Q4 2023, Rocket Lab reported a 36% year-over-year revenue increase to $180 million, primarily driven by new launch contracts with government and commercial clients, showcasing its competitive edge in the aerospace sector.
- Profitability Challenges: Despite revenue progress, the company faces an operating loss of $51 million, largely due to rising R&D costs, highlighting significant hurdles that must be overcome before achieving profitability.
- Valuation Risks: With a market cap of $49 billion and a price-to-sales ratio of 79, significantly higher than the S&P 500's 3.5, Rocket Lab's stock price is under considerable downward pressure, necessitating careful evaluation of its future growth potential.
See More
U.S. Space Force Budget Reaches $71 Billion
- Significant Budget Increase: The U.S. Space Force's budget has reached $71 billion, with $40 billion allocated for research and development of new space infrastructure, indicating a strong demand for advanced technologies that could boost stock prices of related companies.
- Surge in Material Demand: In 2026, demand for aerospace and defense thermoplastic composites surged by 32% year-over-year to $731 million, highlighting a supply chain gap that may funnel capital toward companies positioned to address this mismatch.
- Expanded Technical Collaboration: Starfighters Space has broadened its technical interchange agreement with Blackstar Orbital to include vehicle integration and wind tunnel testing, enhancing their collaborative potential in hypersonic spacecraft development, which could accelerate time-to-market for new products.
- Optimistic Market Outlook: Karman reported a fiscal year 2025 revenue of $471.5 million, up 36.6%, and raised its 2026 revenue outlook to $715 million to $730 million, reflecting strong growth trends in the defense and space markets that may attract more investor interest.
See More
U.S. Space Force Budget Reaches $71 Billion
- Significant Budget Increase: The U.S. Space Force's budget has reached $71 billion, with $40 billion allocated for research and development of new space infrastructure, indicating a pressing need for advanced technologies in the defense industrial base as funding flows in faster than facilities and workforce can absorb.
- Surge in Material Demand: In 2026, demand for aerospace and defense thermoplastic composites surged 32% year-over-year to $731 million, highlighting a structural mismatch between defense industrial needs and supply chain capabilities, which is directing capital towards companies positioned at the bottleneck.
- Expanded Technical Collaboration: Starfighters Space has broadened its technical interchange with Blackstar Orbital to include integration engineering and wind tunnel testing, aiming to accelerate the flight testing of reusable hypersonic spacecraft, thereby enhancing their partnership in the aerospace sector.
- Optimistic Market Outlook: Karman reported a fiscal year 2025 revenue of $471.5 million, up 36.6%, and raised its 2026 revenue outlook to $715 million to $730 million, reflecting strong demand in national security and commercial space access markets.
See More
Rocket Lab Expands Business Through Defense Contracts and Acquisitions
- Defense Contract Growth: Rocket Lab is significantly expanding its business through defense contracts, indicating a growing market potential in the defense sector that could provide strong support for future revenue growth.
- Acquisition Strategy: The company enhances its satellite systems capabilities through acquisitions, which not only boosts its technological strength but also positions it to capture more market share in the competitive aerospace industry, further solidifying its market position.
- New Rocket Development: Rocket Lab is developing the Neutron rocket, which is expected to bring new revenue streams, particularly in the commercial launch services sector, thereby enhancing its competitive edge in the market.
- Valuation and Execution Risks: Despite the optimistic outlook, the stock's premium valuation means that execution is critical, and investors need to monitor the company's ability to sustain growth to avoid potential price correction risks.
See More
ARK Investment Management Increases NTLA Holdings
- Consistent NTLA Accumulation: ARK Investment Management has steadily increased its holdings in Intellia Therapeutics (NTLA) throughout 2026, acquiring over 263,848 shares from January to April, with a potential investment exceeding $3.5 million, reflecting a strong long-term confidence in the biotech firm.
- Positive Clinical Trial Results: Intellia recently reported positive Phase 3 trial results for lonvoculin ziclumeran (lonvo-z) for hereditary angioedema treatment and has initiated a rolling Biologics License Application submission to the FDA, aiming for a potential U.S. launch in the first half of 2027.
- Rocket Lab Stock Sale: ARK's second sale of Rocket Lab (RKLB) stock this month involved offloading 50,312 shares, potentially worth over $4 million, indicating a strategy to lock in gains after RKLB's impressive 262% rise over the past year.
- Retail Investor Sentiment: On Stocktwits, retail sentiment for NTLA is in the 'extremely bullish' territory, while RKLB is 'bullish', suggesting positive market expectations for both stocks, despite ARKK and ARKQ showing 'bearish' sentiment.
See More
Jim Cramer's Insights on Various Stocks
- Joby Aviation Risk Assessment: Joby Aviation is deemed too risky, with analysts advising new investors to be cautious to avoid disappointment from potential stock price drops, which could hinder its ability to attract new investors.
- BillionToOne Potential: Despite the overall poor performance of diagnostic companies, BillionToOne is viewed as a potential winner, with analysts believing its future performance is promising, which may draw more investor interest in its stock.
- Boston Scientific Competitive Pressure: Boston Scientific faces intense competition, with analysts noting that its market position is under threat; however, there is still potential for a rebound, prompting investors to watch for a price bottom before deciding to buy.
- Rocket Lab Investment Opportunity: Rocket Lab is considered a speculative stock worth investing in, with analysts optimistic about its future performance, especially leading up to the SpaceX IPO, which could attract more speculative investments.
See More
